combined approach multidrug-resistant leukemic cell lines bone marrow monoclonal antibody chemotherapy Selective removal malignant cells bone marrow BM concern autologous BM transplantation ABMT Use vincristine doxorubicin purging ineffective presence multidrug-resistant MDR tumor cells particular problem monoclonal antibody cell surface product MDR gene P-glycoprotein effective selective removal MDR cells BM rabbit complement different cell lines selectively MDR-positive cells rounds antibody kill CEM/VLB cells Mixtures malignant cells normal BM removal removal CEM/VLB clonogenic cells treatment normal committed precursors alone addition cytotoxic agent etoposide antibody results log reduction malignant cells antibody effective patients leukemic blasts results use effective selective removal MDR cells BM ABMT addition purging efficacy 